In this podcast series, Alex Shandrovsky interviews investors about benchmarks for funding Alt Proteins in 2025 and uncovers the investment playbooks of successful Climate Tech CEOs and Leading VCs.
Podcast Host Alex Shandrovksy is a strategic advisor to numerous global food tech accelerators and companies, including alternative proteins and cellular agriculture leaders. His focus is on investor relations and post-raise scale for agrifood tech companies. This podcast is syndicated through our media partners; Foodtech Weekly and Vegconomist.
Episode 30: SuperGut
In this episode, we sat down with Marc Washington, founder and Executive Chairman of Supergut, to unpack how the brand became a breakout leader at the intersection of gut health and the GLP-1 wave. Alongside guest co-host Lance Lively of The Gut Punch, we explored the science and strategy behind Supergut’s rise—from investing in gold-standard clinical trials and securing key patents, to securing national retail launches and bringing on the former CEO of Vital Proteins to lead their next phase of growth. Marc shared the inside story behind their recent fundraise led by Full Frame Growth Partners, their bold clinical trial strategy, and how they’ve positioned Supergut to stand out in a noisy space of fast followers. From product formulation to rebranding to omnichannel expansion, this conversation offers a masterclass in building a truly differentiated CPG brand in the Ozempic era.
Key Facts SuperGut:
- Goal: To make a sort of gut health, infinitely more accessible, truly functional foods that are both highly efficacious, but also making great tasting, convenient, accessible products.
- Recently secured a “significant growth equity investment” from Full Frame Growth Partners.
Alex’s Top Findings:
- Clinical Research as a Brand Moat. While others slapped on health claims, Supergut invested in gold-standard science—earning credibility that 99% of wellness brands can’t touch. “ It was over a million dollars that we spent on a clinical research for a study of that size and magnitude. Now we’re incredibly happy that we went through a very expensive, time-consuming exercise of doing a gold standard clinical study. It’s a real credible science behind it. Randomized double-blind, placebo-controlled clinical study. Close to 200 participants did it. We saw significant impact on many different dimensions of health, inclusive of metabolic health, significantly better blood sugar, better weight, better appetite control as well.”
- Be Always Fundraising. Relationships started a year before the check was written. The deal was built over time—not overnight. “ We weren’t actively raising, but as an entrepreneur, you’re always fundraising in one form or another.”
Ask Investors for Their Take. Marc used investor meetings not just to pitch—but to test value props, weed out weak fits, and gather strategic insight. “ I would typically share at least a high-level overview of what we’re doing right, and our unique value proposition. Instead of continuing to go down that pathway of revealing more about the business, I would turn the tables right and ask the investors, “So given what I’ve shared, what do you think is unique about what we’re doing and how would you think about positioning this in the marketplace relative to what you’re seeing?” So kind of turning the tables, almost like an interview of them to see if they got us.”
Link to Apple Podcast here.
Catch the full podcast series here.
